Ladenburg Thalmann Maintains Buy on Alpha Tau Medical, Raises Price Target to $14

Ladenburg Thalmann analyst Jeff Cohen maintains Alpha Tau Medical (NASDAQ:DRTS) with a Buy and raises the price target from $12 to $14.